Study reveals contraceptive cancer risks

March 7, 2012, Australian National University
Study reveals contraceptive cancer risks
Professor Emily Banks. Photo by Belinda Pratten.

A study has revealed that injectable contraceptives that are widely used around the world influence the risk of developing several types of cancer.

The study team was led by Ms Margaret Urban at the National Health Laboratory Service (NHLS) in Johannesburg and Professor Emily Banks of The Australian National University. Professor Banks said the study builds on previous research that found that women using have a temporarily increased risk of breast cancer and and a decreased risk of and cancer of the lining of the .

“Our study confirms previous findings that the use of oral hormonal contraceptives is associated with an increased risk of breast and cervical cancer,” said Professor Banks.

“We have also shown for the first time that injectable hormonal contraception use independently increases the risk of developing these cancers to a similar extent as oral contraceptives, and that these risks wear off over time.”

The researchers found that South African women who had recently used one or both of these contraception methods were about 1.7 times more likely to develop and 1.4 times more likely to develop cervical cancer  than women who had never used hormonal contraception.

However, this increased risk disappeared within a few years after women stopped taking the contraception.

The study also supports previous findings that extended use of hormonal contraception is associated with a reduced risk of ovarian cancer and cancer of the lining of the womb.

“Over 60 million women are using injectable contraceptives world wide. These findings fill an important gap in knowledge, which will inform women’s contraception choices,” said Ms Urban.

“The temporary increase in the risk of breast and cervical cancer and the long term protection against ovarian and endometrial cancers need to be considered alongside the highly effective that these medications provide,” said Ms. Urban.

The study, involving more than 3,500 black women, was run as part of the Johannesburg Cancer Case Control Study at Johannesburg public hospitals and was chiefly funded by the NHLS and the South African Medical Research Council. Among black South African women, injectable contraceptives are used more commonly than the oral contraceptive pill.

Oral contraceptive pills contain man-made versions of the female sex hormones estrogen and progesterone, while injectable contraceptives usually only contain progesterone.

The paper is published today in PLoS Medicine.

Explore further: Study in Lancet finds use of hormonal contraception doubles HIV risk

Related Stories

Study in Lancet finds use of hormonal contraception doubles HIV risk

October 3, 2011
Women using hormonal contraception --such as a birth control pill or a shot like Depo-Provera – are at double the risk of acquiring HIV, and HIV-infected women who use hormonal contraception have twice the risk of transmitting ...

Study confirms some contraceptive pills more likely to cause blood clots

October 25, 2011
A study published in the British Medical Journal today confirms previous findings that certain oral contraceptive pills are more likely to cause serious blood clots (venous thromboembolism - VTE ) than others.

Studies show increased risk of blood clots when taking oral contraception with drospirenone

April 21, 2011
(PhysOrg.com) -- Two new drug safety studies conducted by researchers at Boston University School of Medicine (BUSM) provide strong evidence that women taking oral contraception with drospirenone have an increased risk of ...

Pill and pregnancy have biggest effects on ovarian cancer risk

October 26, 2011
(Medical Xpress) -- Taking the Pill for 10 years can reduce the risk of ovarian cancer by almost half (45 per cent), new research part-funded by Cancer Research UK shows today.

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.